HaemaLogiX Ltd
Focusing on the development and commercialisation of novel immuno-oncology and immune-therapies.
Focusing on the development and commercialisation of novel immuno-oncology and immune-therapies.
HaemaLogiX Ltd is a biotechnology and healthcare startup founded in 2014 in Australia. The company focuses on the development and commercialization of novel immuno-oncology and immune-therapies, with a mission to improve the quality of life for patients suffering from blood cancers and autoimmune diseases. HaemaLogiX is currently engaged in several inter-related research and clinical development projects aimed at validating antigen targets and products. The latest significant milestone for HaemaLogiX was a $10.00M Venture Round investment on 08 September 2021. The investment was led by Platinum Asset Management, a prominent player in the venture capital arena. HaemaLogiX's commitment to pioneering advancements in immuno-oncology and immune-therapies, combined with its recent substantial investment, positions the company for notable growth and potential breakthroughs in the treatment of blood cancers and autoimmune diseases.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $10.00M | 2 |
|
08 Sep 2021 |
No recent news or press coverage available for HaemaLogiX Ltd.
We care about your data, and we'd love to use cookies make your experience better.
